Holen Sie sich die Stockscreener-App
159.36
0.17%
-0.27
Handel nachbörslich:
159.36
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$159.63
Offen:
$161.37
24-Stunden-Volumen:
2.53M
Relative Volume:
1.08
Marktkapitalisierung:
$45.33B
Einnahmen:
$21.92B
Nettoeinkommen (Verlust:
$1.76B
KGV:
26.03
EPS:
6.1223
Netto-Cashflow:
$2.63B
1W Leistung:
-4.64%
1M Leistung:
-9.40%
6M Leistung:
-14.71%
1J Leistung:
-28.47%
1-Tages-Spanne:
$158.93
$162.41
1-Wochen-Bereich:
$158.20
$167.06
52-Wochen-Spanne:
$158.20
$233.51
Becton Dickinson Co Stock (BDX) Company Profile
Firmenname
Becton Dickinson Co
Sektor
Telefon
(201) 847-6800
Adresse
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
159.36 | 45.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 170.20B | 10.06B | 2.88B | 2.49B | 7.876 |
|
ALC
Alcon Inc
|
77.32 | 38.26B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.33B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.86B | 5.40B | 1.49B | 1.78B | 10.12 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-03 | Fortgesetzt | Citigroup | Buy |
| 2025-09-25 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-02 | Herabstufung | Goldman | Buy → Neutral |
| 2025-05-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-05-30 | Eingeleitet | Goldman | Buy |
| 2023-07-24 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Overweight |
| 2023-05-05 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-12-12 | Hochstufung | Citigroup | Sell → Neutral |
| 2022-07-11 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-06-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | Fortgesetzt | Raymond James | Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-06-01 | Fortgesetzt | Goldman | Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-07 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-02-07 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | Herabstufung | Cowen | Outperform → Market Perform |
| 2020-01-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-05-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-07 | Eingeleitet | Deutsche Bank | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-06-21 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-04-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-01-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-01-05 | Hochstufung | Citigroup | Sell → Neutral |
| 2018-01-05 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2017-12-29 | Bestätigt | Deutsche Bank | Buy |
Alle ansehen
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Assessing Becton Dickinson (BDX) Valuation After Recent Share Price Weakness And Planned Business Separation - simplywall.st
Organizations urged to adopt smarter safety solutions, Becton Dickinson recommends - Traders Union
Deals tracker: Aveanna Healthcare to acquire Family First Healthcare - Modern Healthcare
Becton, Dickinson and Company $BDX Shares Bought by Legal & General Group Plc - MarketBeat
Bank of Montreal Can Sells 17,183 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson Recieves FDA Clearance for Surgiphor 1000 ml Irrigation System - Yahoo Finance UK
Becton Dickinson expands robotics offering with Sinteco to streamline pharmacy operations - Traders Union
Richard Bernstein Advisors LLC Sells 8,405 Shares of Becton, Dickinson and Company $BDX - MarketBeat
First Trust Advisors LP Has $55.52 Million Stake in Becton, Dickinson and Company $BDX - MarketBeat
[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis) - GlobeNewswire Inc.
Becton Dickinson at Barclays Conference: Strategic Growth and Innovation - Investing.com
Swiss National Bank Trims Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Natixis Advisors LLC Has $57.56 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Clarkston Capital Partners LLC Grows Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
BD Product Launches Test Infection Control Story As Shares Weaken - simplywall.st
Ex-Dividend Reminder: Ormat Technologies, Becton, Dickinson and Elevance Health - Nasdaq
BD Advances Iliac Artery Treatment Across the European Union - Becton Dickinson
Becton, Dickinson and Company (BDXB) Competitors - Meyka
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $221 - 富途牛牛
Becton, Dickinson and Company $BDX Stake Boosted by First Eagle Investment Management LLC - MarketBeat
Elo Mutual Pension Insurance Co Increases Holdings in Becton, Dickinson and Company $BDX - MarketBeat
A Look At Becton Dickinson (BDX) Valuation After Recent Weak Share Price Momentum - simplywall.st
Barclays Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Maintains Target Price $202 - 富途牛牛
Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a Potential 11.71% Upside in the Healthcare Sector - DirectorsTalk Interviews
Becton Dickinson (BDX) Secures FDA Clearance for Innovative Irri - GuruFocus
Becton, Dickinson and Company $BDX Position Trimmed by Laurel Wealth Advisors LLC - MarketBeat
BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor 1000mL for Wound Irrigation - Finviz
FDA clears 1L surgical rinse designed to boost safety in the OR - Stock Titan
Is Becton, Dickinson and Company Stock Outperforming the Dow? - Barchart.com
Xponance Inc. Reduces Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
DNB Asset Management AS Reduces Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company Trade Ideas — LSX:857675 - TradingView
Becton, Dickinson and Company (BDX): A Bull Case Theory - Finviz
American Century Companies Inc. Sells 162,854 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) EVP Sells $13,638.00 in Stock - MarketBeat
Feld, Becton Dickinson’s EVP, sells $13,638 in stock - Investing.com
Feld, Becton Dickinson’s EVP, sells $13,638 in stock By Investing.com - Investing.com Canada
Quote and Chart - Becton Dickinson
Mitsubishi UFJ Asset Management Co. Ltd. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
What's Going On With Becton Dickinson Stock Tuesday? - Sahm
Close Asset Management Ltd Sells 395,644 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $195 - 富途牛牛
Becton, Dickinson and Company (BDX) Announces Early Tender Resul - GuruFocus
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase - Becton Dickinson
Becton Dickinson Expands Debt Tender Offers Amid Strong Demand - TipRanks
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap - Becton Dickinson
Point of Care Diagnostics Market Competitive Landscape - GlobeNewswire
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 PlayersSysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics - Yahoo Finance
Finanzdaten der Becton Dickinson Co-Aktie (BDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.50%
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):